22 October 2022>: Articles
Association Between Parafibromin Expression and Presence of Brown Tumors and Jaw Tumors in Patients with Primary Hyperparathyroidism: Series of Cases with Review of the Literature
Challenging differential diagnosis, Unusual setting of medical care, Rare disease, Congenital defects / diseases, Educational Purpose (only if useful for a systematic review or synthesis), Rare coexistence of disease or pathology
Michał Popow A , Monika Kaszczewska A , Magdalena Góralska B , Piotr Kaszczewski B* , Agata Skwarek-Szewczyk B , Witold Chudziński B , Krystian Jażdżewski B , Monika Kolanowska B , Magdalena Bogdańska B , Aleksandra Starzyńska-Kubicka B , Zbigniew Gałązka EDOI: 10.12659/AJCR.936135
Am J Case Rep 2022; 23:e936135
Figure 1. Staining for parafibromin in group of patients with brown tumors. (A) Physiological hematoxylin eosin staining of healthy parathyroid gland. (B) Physiological parafibromin staining of healthy parathyroid gland. (C) Primary hyperparathyroidism and brown tumors in ribs in patient 2. (D) Primary hyperparathyroidism and multiple brown tumors in ribs, pelvis, lower limbs, and mandibula in patient 3. (E) Primary hyperparathyroidism and brown tumor in sternum in patient 4. (F) Recurrent primary hyperparathyroidism and multiple brown tumors in lower and upper limbs in patient 1. (G) Primary hyperparathyroidism, multiple brown tumors in lower and upper limbs, and severe bone deformities in patient 4.